Skip To Main Content
Marco Barbariga on Muck Rack

Marco Barbariga

As seen in: Stem Cell Reports
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Marco

Contact Marco, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Substance P/neurokinin-1 receptor pathway blockade ameliorates limbal stem cell deficiency by modulating mTOR pathway and preventing cell senescence

|
By Bykova T.V, Romina Lasagni Vitar, Francesca Triani, Marco Barbariga, Giulio Ferrari, Philippe Fonteyne, Paolo Rama
| Stem Cell Reports Verified
Highlights • Substance P inhibition improves corneal wound healing and transparency • Substance P aggravates corneal SCD by stimulation of mTOR pathway and cell senescence • Corneal epithelial stem cells express NK1R • Topical NK1R antagonists represents an attractive option to treat corneal SCD Summary Severe ocular surface diseases can lead to limbal stem cell deficiency (LSCD), which is accompanied by defective healing.
Open in Who Shared Issue with article?

STAT3 precedes HIF1α transcriptional responses to oxygen and oxygen and glucose deprivation in human brain pericytes

|
By Robert N. E. Carlsson, Ilknur Özen, Marco Barbariga, Abderahim Gaceb
| PLOS
Brain pericytes are important to maintain vascular integrity of the neurovascular unit under both physiological and ischemic conditions. Ischemic stroke is known to induce an inflammatory and hypoxic response due to the lack of oxygen and glucose in the brain tissue. How this early response to ischemia is molecularly regulated in pericytes is largely unknown and may be of importance for future therapeutic targets.
Open in Who Shared Issue with article?
See all 2 articles